This inventor holds 3 USPTO granted patents. Top assignees: Welfide Corporation, Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 2000-2002.
Company Filing History:
2 out of 13 
1 out of 198 Years Active: 2000-2002
Title: Tae Kitamura: Innovator in Immunoglobulin Preparation
Introduction
Tae Kitamura is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of immunology, particularly in the development of immunoglobulin preparations for intravenous injection. With a total of 3 patents to his name, Kitamura's work has the potential to impact medical treatments significantly.
Latest Patents
Kitamura's latest patents focus on methods for producing room temperature storable immunoglobulin preparations for intravenous injection. The first patent describes a method that involves fractionating an immunoglobulin-containing solution with 4 to 10 w/v% of polyethylene glycol, which has a molecular weight ranging from 1,000 to 10,000. This process is conducted at a pH value between 4.5 and 6.5, an ionic strength of 0.0001 to 0.1 M, and a temperature of 0 to 4°C to recover a supernatant fraction. The supernatant fraction is then concentrated at a pH of 3.5 to 5.0. The second patent reiterates this method, emphasizing its importance in producing stable immunoglobulin preparations.
Career Highlights
Throughout his career, Kitamura has worked with reputable companies such as Welfide Corporation and Yoshitomi Pharmaceutical Industries, Ltd. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Kitamura has collaborated with notable coworkers, including Yutaka Hirao and Motonori Hashimoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tae Kitamura's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work in developing room temperature storable immunoglobulin preparations has the potential to enhance medical treatments and improve patient care.